tiprankstipranks
TherapeuticsMD (TXMD)
NASDAQ:TXMD

TherapeuticsMD (TXMD) Financial Statements

2,213 Followers

TherapeuticsMD Financial Overview

TherapeuticsMD's market cap is currently ―. The company's EPS TTM is $-1.45; its P/E ratio is -1.55; TherapeuticsMD is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ -53.00K$ 437.00K$ 416.00K$ 1.15M$ 20.92M
Gross Profit$ -53.00K$ 437.00K$ 416.00K$ 13.14M$ 17.13M
EBIT$ -1.41M$ -2.37M$ -2.26M$ -104.05M$ -26.97M
EBITDA$ -1.28M-$ -2.23M$ -106.04M$ -25.94M
Net Income Common Stockholders$ -3.38M$ -2.41M$ -2.31M$ -33.22M$ -28.96M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.17M$ 13.73M$ 17.25M$ 49.32M$ 27.08M
Total Assets$ 50.49M$ 53.69M$ 59.54M$ 90.46M$ 133.91M
Total Debt$ 6.74M$ 6.94M$ 7.13M$ 7.37M$ 102.54M
Net Debt$ -3.43M$ -6.79M$ -10.11M$ -41.95M$ 75.46M
Total Liabilities$ 22.44M$ 22.49M$ 27.58M$ 55.31M$ 182.18M
Stockholders Equity$ 28.05M$ 31.20M$ 32.02M$ 35.14M$ -48.27M
Cash Flow-
Free Cash Flow$ -6.03M-$ -8.70M$ 73.17M$ -18.95M
Operating Cash Flow$ -6.03M$ -3.39M$ -8.70M$ 73.21M$ -18.92M
Investing Cash Flow---$ -142.67M$ -31.00K
Financing Cash Flow$ -1.00K$ 44.00K$ 1.11M$ -129.95M$ 19.73M
Currency in USD

TherapeuticsMD Earnings and Revenue History

TherapeuticsMD Debt to Assets

TherapeuticsMD Cash Flow

TherapeuticsMD Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis